- Home
- TLPH vs MYO Comparison
TLPH vs MYO Comparison
Compare TLPH & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLPH | MYO |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 36.9M |
| IPO Year | 2010 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TLPH | MYO |
|---|---|---|
| Price | $0.78 | $0.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $6.00 | ★ $7.67 |
| AVG Volume (30 Days) | 239.4K | ★ 414.0K |
| Earning Date | 05-13-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,151,000.00 | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $15.92 |
| Revenue Next Year | N/A | $21.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $0.38 | $0.63 |
| 52 Week High | $1.57 | $5.59 |
Technical Indicators
Market Signals| Indicator | TLPH | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 38.79 | 41.26 |
| Support Level | $0.41 | $0.63 |
| Resistance Level | $0.79 | $1.03 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 5.67 | 31.87 |
Price Performance
Historical ComparisonAbout TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).